#vasnarasimhan — Public Fediverse posts

https://www.europesays.com/ch/129422/ Novartis Needs Board Shakeup, M&A Revamp, Investor Tells Reuters #acquisitions #CSuite #CapitalMarkets #ChiefExecutiveOfficer #GiovanniCaforio #industries #Investing #Markets #mergers #Novartis #NOVARTISAGREG #VasNarasimhan

https://www.europesays.com/ch/129274/ Novartis investors turn spotlight on M&A after trial setbacks #Avidity #investors #MergersAndAcquisitions #Narasimhan #Novartis #VasNarasimhan

https://www.europesays.com/ch/129258/ Novartis investors turn spotlight on M&A after trial setbacks #Avidity #investors #MergersAndAcquisitions #Narasimhan #Novartis #VasNarasimhan

https://www.europesays.com/ch/129246/ Novartis investors turn spotlight on M&A after trial setbacks #Avidity #investors #MergersAndAcquisitions #Narasimhan #Novartis #VasNarasimhan

https://www.europesays.com/ch/128863/ Shareholder Calls for Novartis Board Overhaul Amid Acquisition Struggles #Acquisition #BoardOverhaul #CorporateGovernance #DavidSamra #drugmaker #Novartis #setbacks #SharePrice #Shareholder #VasNarasimhan

https://www.europesays.com/ch/127933/ Twin drug setbacks pile pressure on Novartis pipeline, CEO #BiotechInvestmentNews #DrugDevelopmentSetbacks #Novartis #NovartisSharePriceDrop #PelacarsenTrialFailure #PharmaceuticalPipelinePressure #VasNarasimhan

https://www.europesays.com/ch/127791/ Novartis Suffers Third Clinical Setback in a Week; Shares Plunge 13% in Early US Trading, Erasing Over $40 Billion in Market Value — BigGo Finance #(delBrax) #AvidityBiosciences #Barclays #DelDesiran #HARBORStudy #Jefferies #Novartis #Pelacarsen #remibrutinib #VasNarasimhan

https://www.europesays.com/ch/127447/ Novartis faces third clinical-trial setback in a week as muscle drug fails | World News #AvidityBiosciences #ClinicalTrial #DelDesiran #DrugFailure #DrugPipeline #MyotonicDystrophy #Novartis #NovartisShares #PharmaceuticalSector #Roche #VasNarasimhan

https://www.europesays.com/ch/117496/ Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen #AIAndMachineLearning #Anthropic #ArtificialIntelligence #CorporateGovernance #Executives #FierceBiotechHomepage #FiercePharmaHomepage #Novartis #Pharma #VasNarasimhan

https://www.europesays.com/ch/114993/ Novartis CEO shrugs off oral PCSK9 threat amid Q2 growth #CholesterolDrug #Earnings #FiercePharmaHomepage #financials #Leqvio #marketing #Merck&Co #Novartis #PCSK9 #PCSK9Drugs #Pharma #PharmaCEO #VasNarasimhan

https://www.europesays.com/ch/107332/ Novartis profit beats estimates, signals return to growth #CancerDrugs #growth #HeartDisease #Novartis #NovartisAG #SkinDisease #VasNarasimhan

https://www.europesays.com/ch/107018/ Novartis Profit Beats Estimates, Signals Return to Growth #acquisitions #cancer #ChiefExecutiveOfficer #china #drugs #Earnings #industries #Novartis #NOVARTISAGREG #RocheHoldingAG #shopping #VasNarasimhan

https://www.europesays.com/ch/107004/ Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline #BigPharma #Novartis #NovartisAG #VasNarasimhan

https://www.europesays.com/ch/106986/ Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline #BigPharma #Novartis #NovartisAG #VasNarasimhan

https://www.europesays.com/ch/106438/ AI is helping speed up the timelines of drug discovery, Novartis CEO says #JulieHyman #Novartis #VasNarasimhan

https://www.europesays.com/ch/?p=106190 Novartis Stock Gains On Core Operating Income, Volume Growth In Q2; Backs Outlook #BreakingNews #BreakingNewsHeadlinesToday #BreakingNewsNow #BreakingNewsToday #BreakingNewsUnitedStates #EarningsCall #EarningsPerShare #EarningsReports #EarningsToday #NetEarnings #Novartis #NovartisEarnings #pharmaceutical #SwissPharmaceuticalMajor #VasNarasimhan

https://www.europesays.com/ch/?p=106033 Novartis Stock Gains On Core Operating Income, Volume Growth In Q2; Backs Outlook #BreakingNews #BreakingNewsHeadlinesToday #BreakingNewsNow #BreakingNewsToday #BreakingNewsUnitedStates #EarningsCall #EarningsPerShare #EarningsReports #EarningsToday #NetEarnings #Novartis #NovartisEarnings #pharmaceutical #SwissPharmaceuticalMajor #VasNarasimhan

https://www.europesays.com/ch/87205/ Novartis CEO pay soars 30% to $32M in 2025 #Executives #FiercePharmaHomepage #financials #Novartis #NovoNordisk #Pharma #PharmaCEO #PharmaCEOSalary #Roche #VasNarasimhan

https://www.europesays.com/ch/86538/ Novartis CEO eyes 2026 growth despite record patent cliff #BTKInhibitors #Earnings #Entresto #Executives #FiercePharmaHomepage #financials #Kisqali #launches #Novartis #PatentCliff #PatentExpirations #Pharma #Pluvicto #VasNarasimhan

https://www.europesays.com/ch/86488/ Novartis CEO Narasimhan echoes call for EU drug pricing reform #DonaldTrump #DrugPrices #FiercePharmaHomepage #Novartis #Pharma #tariffs #VasNarasimhan

Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton » Dallas Innovates

Novartis breaks ground on its Denton radioligand therapy site. [Photo: Novartis] Swiss gl…
#Switzerland #CH #Europe #Europa #EU #DepartmentofCommerceUnderSecretaryforIndustryandSecurityJeffreyKessler #Nachrichten #Nouvelles #Novartis #pharmaceuticalmanufacturing #radioligandtherapy #RLT #schweiz #Suisse #switzerland #TexasStateSenatorBrentHagenbuch #VasNarasimhan
https://www.europesays.com/2985151/

Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton » Dallas Innovates https://www.byteseu.com/2014617/ #DepartmentOfCommerceUnderSecretaryForIndustryAndSecurityJeffreyKessler #Novartis #PharmaceuticalManufacturing #RadioligandTherapy #RLT #Switzerland #TexasStateSenatorBrentHagenbuch #VasNarasimhan

https://www.europesays.com/ch/64386/ Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton » Dallas Innovates #DepartmentOfCommerceUnderSecretaryForIndustryAndSecurityJeffreyKessler #Novartis #PharmaceuticalManufacturing #RadioligandTherapy #RLT #Switzerland #TexasStateSenatorBrentHagenbuch #VasNarasimhan

https://www.europesays.com/ch/59507/ Novartis Profit, Sales Decline as Generic Competition Bites #cancer #ChiefExecutiveOfficer #ChiefFinancialOfficer #drugs #Earnings #industries #MorganStanley #MukulMehta #Novartis #NOVARTISAGREG #Switzerland #VasNarasimhan

https://www.europesays.com/ch/57370/ Novartis Q1 Earnings Call Highlights #ChiefFinancialOfficerMukulMehta #Narasimhan #Novartis #OperatingIncome #PercentagePoints #SalesGrowth #US #VasNarasimhan

https://www.europesays.com/ch/54514/ Novartis CEO Vas Narasimhan joins Anthropic board #AIDrug #AnthropicBoard #HealthcareInnovation #Novartis #PharmaAICollaboration #VasNarasimhan

https://www.europesays.com/ch/49707/ Who Is Vas Narasimhan? Novartis CEO Appointed To Anthropic’s Board #AI #Anthropic #Novartis #VasNarasimhan

https://www.europesays.com/ch/49196/ Who is Vas Narasimhan, the Indian origin Novartis CEO who joined Anthropic’s board #AnthropicBoardAppointment #AnthropicBoardOfDirectors #ChrisLiddell #DanielaAmodei #DarioAmodei #JayKreps #Novartis #NovartisCEO #ReedHastings #VasNarasimhan #WhoIsVasNarasimhan #YasminRazavi

https://www.europesays.com/ch/49067/ Novartis CEO Ka Bada Move: AI Se Banegi Nayi Dawa! | Novartis, Anthropic #AI #Anthropic #ArtificialIntelligence #BoardAppointment #ClaudeAI #DrugDiscovery #GenerativeAI #HealthcareAI #LifeSciences #Novartis #PharmaTech #VasNarasimhan

https://www.europesays.com/ch/49033/ Novartis CEO Joins AI Board for Drug Discovery Push #AI #Anthropic #ArtificialIntelligence #BoardAppointment #ClaudeAI #DrugDiscovery #GenerativeAI #HealthcareAI #LifeSciences #Novartis #PharmaTech #VasNarasimhan